Related Experiment Video

Updated: Feb 13, 2026

Assessing Urinary Tract Junction Obstruction Defects by Methylene Blue Dye Injection
06:05

Assessing Urinary Tract Junction Obstruction Defects by Methylene Blue Dye Injection

Published on: October 12, 2017

16.2K

Risk factors for postobstructive diuresis in pediatric patients with ureteropelvic junction obstruction, following

Adriana M Pedraza Bermeo1, Ana María Ortiz Zableh1, Mariangel Castillo2

  • 1Pontificia Universidad Javeriana, Bogotá, Colombia.

Journal of Pediatric Urology
|March 5, 2018
PubMed

Insights

Younger children and those with a history of tubular acidosis may face a higher risk of postobstructive diuresis (POD) after ureteropelvic junction obstruction (UPJO) surgery. This finding highlights potential risk factors for this condition in pediatric patients.

Area of Science:

  • Pediatric Urology
  • Nephrology
  • Surgical Outcomes

Background:

  • Postobstructive diuresis (POD) is a critical condition involving significant salt and water loss after urinary tract obstruction relief.
  • Ureteropelvic junction obstruction (UPJO) is a common cause of fetal kidney dilatation, often requiring pyeloplasty.
  • Limited data exists on risk factors for POD in pediatric patients undergoing pyeloplasty.

Purpose of the Study:

  • To identify potential clinical risk factors for postobstructive diuresis (POD) in pediatric patients after open pyeloplasty for UPJO.

Main Methods:

  • Retrospective case series of 88 pediatric patients with UPJO treated with open pyeloplasty (2006-2016).
  • Analysis of qualitative and quantitative variables associated with POD.
  • Statistical analysis performed using STATA 14 software.

Main Results:

  • Twenty-seven patients (30%) experienced POD.
  • A trend indicated higher POD incidence in younger patients (mean age 20.2 months vs. 72.3 months).
  • Previous diagnosis of tubular acidosis was associated with an increased risk of POD.

Conclusions:

  • Younger age and a history of tubular acidosis may be risk factors for POD in pediatric UPJO patients post-pyeloplasty.
  • This study is one of the larger series on this topic.
  • Prospective studies are needed to validate these findings and inform patient management.
Abstract

Keywords:
DiuresisHydronephrosisPolyuriaRisk factorsUreteric obstruction

More Related Videos

Whole-body PET/MRI of Pediatric Patients: The Details That Matter10:02

Whole-body PET/MRI of Pediatric Patients: The Details That Matter

Published on: December 19, 2017

15.4K
Fundus Photography as a Convenient Tool to Study Microvascular Responses to Cardiovascular Disease Risk Factors in Epidemiological Studies10:11

Fundus Photography as a Convenient Tool to Study Microvascular Responses to Cardiovascular Disease Risk Factors in Epidemiological Studies

Published on: October 22, 2014

19.7K

Related Concept Videos

Factors Affecting the Risk of Infection01:26

Factors Affecting the Risk of Infection

The hosts' susceptibility to infection depends on several factors. The integrity of the skin and mucous membranes helps protect the body against microbial attacks. When the skin is altered, the chance of infection, limb loss, and even death increases.
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
13.9K
Drug Toxicity: Risk factors01:24

Drug Toxicity: Risk factors

Adverse Drug Reactions (ADRs) are potential complications that arise during pharmacotherapy, influenced by multiple risk factors. Age plays a significant role; both neonates and the elderly are at heightened risk due to their respective immature and diminished metabolic and elimination processes. Gender also impacts ADRs, with females experiencing a 1.5 to 1.7-fold greater risk than males, which may be linked to pharmacokinetic, pharmacodynamic, and hormonal differences. Notably, neonates, the...
2
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
279
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
334
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
247
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
311